UIC
SRTA

Uniplan Investment Counsel’s Strata Critical Medical Inc SRTA Stock Holding History

Uniplan Investment Counsel’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53M Buy
1,429,514
+129,197
+10% +$680K 0.71% 43
2026
Q1 		$5.44M Buy
1,300,317
+36,330
+3% +$175K 0.56% 48
2025
Q4 		$6.08M Sell
1,263,987
-1,862
-0.1% -$9.01K 0.61% 44
2025
Q3 		$6.41M Sell
1,265,849
-96,917
-7% -$428K 0.63% 41
2025
Q2 		$5.49M Sell
1,362,766
-365,849
-21% -$1.19M 0.56% 47
2025
Q1 		$4.72M Buy
1,728,615
+754,879
+78% +$2.71M 0.46% 56
2024
Q4 		$4.14M Sell
973,736
-68,311
-7% -$260K 0.38% 68
2024
Q3 		$3.06M Buy
1,042,047
+197,220
+23% +$628K 0.27% 85
2024
Q2 		$2.94M Sell
844,827
-662,990
-44% -$2.21M 0.27% 85
2024
Q1 		$4.3M Buy
1,507,817
+494,226
+49% +$1.52M 0.34% 65
2023
Q4 		$3.65M Buy
1,013,591
+308,497
+44% +$886K 0.27% 73
2023
Q3 		$1.85M Buy
+705,094
New +$2.48M 0.14% 107

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Uniplan Investment Counsel's SRTA Position: Q2 2026 in Review

Uniplan Investment Counsel increased its Strata Critical Medical Inc (SRTA) stake by 9.9% in Q2 2026, buying an estimated $680K and bringing the position to 1,429,514 shares worth $7.53M. The position accounts for 0.71% of the portfolio, ranked #43.

Uniplan Investment Counsel first reported a position in SRTA in Q3 2023 and has held it in 12 quarters since. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Uniplan Investment Counsel held 1,429,514 shares of Strata Critical Medical Inc worth $7.53M as of Q2 2026.
  • Uniplan Investment Counsel bought 129,197 Strata Critical Medical Inc shares in Q2 2026, an estimated $680K.
  • Strata Critical Medical Inc made up 0.71% of Uniplan Investment Counsel's portfolio in Q2 2026, its #43 holding.
  • Uniplan Investment Counsel first reported a position in Strata Critical Medical Inc in Q3 2023 and has held it in 12 quarters since.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.